Resumen
Objetivo: Analizar el potencial terapéutico de productos naturales bioactivos con actividad frente a Treponema pallidum como posibles fuentes para futuras estrategias terapéuticas complementarias. Métodos: Revisión exploratoria en PubMed, ScienceDirect y Scopus, usando los descriptores “Treponema pallidum” AND (“bioactive natural products” OR “natural compounds” OR “plant extracts”), incluyendo tanto estudios in vitro como in silico publicados entre enero de 2005 y enero de 2025. El ácido ftálico (ácido 1,2-bencenodicarboxílico) fue el único compuesto aislado. Sus propiedades farmacocinéticas y toxicológicas se evaluaron con ADMETlab 2.0 y PreADMET, y la biodisponibilidad oral se estimó con SwissADME, generando radar de biodisponibilidad y modelo BOILED-Egg. Resultados: El ácido ftálico, de las flores de Hibiscus rosa-sinensis, presentó zona de inhibición de 24 mm a 10 μg/mL mediante difusión en pozo en agar. Entre los extractos vegetales, el acetónico de Odina wodier mostró mayor actividad antimicrobiana (MIC 0,78 μg/mL; MBC 1,52 μg/mL), seguido por Moringa oleifera y Curculigo orchioides (MIC 3,12 μg/mL). Consideraciones finales: Los productos naturales muestran potencial frente a T. pallidum, pero la predominancia de extractos crudos limita su aplicación clínica, requiriéndose estudios adicionales de aislamiento y seguridad.
Referencias
ÁLVAREZ-MARTÍNEZ FJ, et al. Tackling antibiotic resistance with compounds of natural origin: a comprehensive review. Biomedicines, 2020; 8(10): 1–30.
ALZANDI AA, et al. Antibacterial activity of some medicinal plants in Al Baha region, Saudi Arabia, against carcinogenic bacteria related to gastrointestinal cancers. Journal of Gastrointestinal Cancer, 2023; 54(1): 51-55.
ATANASOV AG, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov, 2021; 20(3): 200-216.
BRASIL. Secretaria de Vigilância em Saúde e Ambiente. Boletim Epidemiológico – Sífilis 2025. 2025. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/boletins-epidemiologicos/2025/boletim_sifilis_2025.pdf. Acesso em: 10 de outubro de 2025.
BEZERRA WAS, et al. Virtual screening of natural products as potential inhibitors of triosephosphate isomerase of Rhipicephalus microplus. Revista Eletrônica Acervo Saúde, 2024; 24(12): 1-10.
DAINA A, et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 2017; 7: 1-13.
DAINA A, ZOETE V. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem, 2016; 11(11): 1117-1121.
DWIVEDI UN, et al. Treponema pallidum putative novel drug target identification and validation: rethinking syphilis therapeutics with plant-derived terpenoids. OMICS, 2015; 9(2): 104-114.
FARVA K, et al. Phenotypic analysis, molecular characterization, and antibiogram of caries-causing bacteria isolated from dental patients. Microorganisms, 2023; 11(8): 1-27.
GAJIC I, et al. Nature’s Arsenal: Uncovering Antibacterial Agents Against Antimicrobial Resistance. Antibiotics, 2025; 14(3): 1-34.
GUEDES BN, et al. Natural antibiotics against antimicrobial resistance: sources and bioinspired delivery systems. Brazilian Journal of Microbiology, 2024; 55: 2753–2766.
GUTTMAN Y, KEREM Z. Computer-aided (in silico) modeling of cytochrome P450-mediated food-drug interactions (FDI). International Journal of Molecular Sciences, 2022; 23(15): 1-13.
HALAWA EM, et al. Antibiotic action and resistance: updated review of mechanisms, spread, influencing factors, and alternative approaches for combating resistance. Frontiers in Pharmacology, 2024; 14: 1-17.
HAO DC, XIAO PG. Pharmaceutical resource discovery from traditional medicinal plants: Pharmacophylogeny and pharmacophylogenomics. Chinese Herbal Medicines, 2020; 12(2): 104-117.
HUBATSCH I, et al. Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nature Protocols, 2007; 2(9): 2111-2119.
JAISWAL AK, et al. The Critical Role of Penicillin in Syphilis Treatment and Emerging Resistance Challenges. Diseases, 2025; 3(2): 1-10.
JI P, et al. Recent advances in small molecule LpxC inhibitors against gram-negative bacteria (2014–2024). Frontiers in Microbiology, 2025; 16: 1-14.
KADRY H, et al. A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids and Barriers of the CNS, 2020; 17(1): 1-24.
LAMBRINIDIS G, et al. In vitro, in silico and integrated strategies for the estimation of plasma protein binding: a review. Advanced Drug Delivery Reviews, 2015; 86: 27-45.
LEE CJ, et al. Species-Specific and Inhibitor-Dependent Conformations of LpxC: Implications for Antibiotic Design. Chemistry & Biology, 2011; 18(1):38-47.
MEHTA P, et al. The rise of syphilis: a call to action for dermatologists. Lancet Infect Dis, 2024; 24(4): 219-220.
MERCURI SR, et al. Syphilis: a mini review of the history, epidemiology and focus on microbiota. New Microbiol, 2022; 45(1): 28-34.
MIELNICZUK S, et al. Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity. Journal of Medicinal Chemistry, 2024; 67(19):17363-17391.
MIYAKE T, et al. Quantitative prediction of P-glycoprotein-mediated drug-drug interactions and intestinal absorption using humanized mice. British Journal of Pharmacology, 2021; 178(21): 4335-4351.
MOLINI BJ, et al. Macrolide resistance in Treponema pallidum correlates with 23S rDNA mutations in recently isolated clinical strains. Sexually Transmitted Diseases, 2016; 43(9): 579-83.
PILON AC, et al. Metabolômica de plantas: métodos e desafios. Química Nova, 2020; 43 (3): 329-354.
ROSSET F, et al. The Epidemiology of Syphilis Worldwide in the Last Decade. Journal of Clinical Medicine, 2025; 14(15): 1-17.
RUBAB M, et al. Preservative effect of Chinese cabbage (Brassica rapa subsp. pekinensis) extract on their molecular docking, antioxidant and antimicrobial properties. PLOS ONE, 2018; 13(10): 1-20.
SADOGHI B, et al. Syphilis. J. Dtsch. Dermatol. Ges., 2023; 21(5): 504-517.
SANGUINETTI MC, MITCHESON JS. Predicting drug-hERG channel interactions that cause acquired long QT syndrome. Trends in Pharmacological Sciences, 2005; 26(3): 119–124.
SHEKHAWAT B, POKHARKAR VB. Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. Acta Pharm. Sin. B, 2017; 7(3): 260-280.
SILVA RV, et al. Penicilina: da descoberta ao patenteamento do processo de produção em larga escala. História, Ciências, Saúde – Manguinhos, 2024; 31: 1-19.
TONG JB, et al. Structural investigation of tetrahydropteridin analogues as selective PLK1 inhibitors for treating cancer through combined QSAR techniques, molecular docking, and molecular dynamics simulations. Journal of Molecular Liquids, 2021; 335: 1-17.
VIJAYAKUMAR S, et al. Identification and isolation of antimicrobial compounds from the flower extract of Hibiscus rosa-sinensis L: in silico and in vitro approaches. Microbial Pathogenesis, 2018; 123: 527-535.
WADAPURKAR RM, et al. In silico drug design for Staphylococcus aureus and development of host-pathogen interaction network. Informatics in Medicine Unlocked, 2018; 10: 58-70.
XU C, et al. In silico prediction of chemical Ames mutagenicity. Journal of Chemical Information and Modeling, 2012; 52(11): 2840-2847.
YABESH JEM, et al. Screening the antimicrobial potential of twelve medicinal plants against venereal diseases causing pathogens. Acta Ecologica Sinica, 2019; 39(5): 356-361.
ZOUINE N, et al. A comprehensive review on medicinal plant extracts as antibacterial agents: Factors, mechanism insights and future prospects. Scientific African, 2024; 26: 1-25.
